Please do not leave this page until complete. This can take a few moments.
GTC Biotherapeutics Inc. of Framingham has entered into a licensing agreement with a Korean drug company that intends to create a transgenic production system for human insulin.
Under the agreement, GTC will establish the cell lines necessary for JCOM Co. Inc. of Korea to produce recombinant human insulin. JCOM, which specializes in cloning and stem cell research, will have exclusive marketing rights for the product in Asia. JCOM will compensate GTC for the development of the transgenic system.
JCOM will also pay GTC a royalty on any commercial sales of the new products.
GTC received U.S. Food and Drug Administration for its flagship product ATryn last week. ATryn is a protein based treatment for blood clots. The protein is produced in the milk of genetically modified goats.
Stay connected! Every business day, WBJ Daily Report will be delivered to your inbox by noon. It provides a daily update of the area’s most important business news.
Sign upWorcester Business Journal provides the top coverage of news, trends, data, politics and personalities of the Central Mass business community. Get the news and information you need from the award-winning writers at WBJ. Don’t miss out - subscribe today.
SubscribeWorcester Business Journal presents a special commemorative edition celebrating the 300th anniversary of the city of Worcester. This landmark publication covers the city and region’s rich history of growth and innovation.
See Digital EditionStay connected! Every business day, WBJ Daily Report will be delivered to your inbox by noon. It provides a daily update of the area’s most important business news.
Worcester Business Journal provides the top coverage of news, trends, data, politics and personalities of the Central Mass business community. Get the news and information you need from the award-winning writers at WBJ. Don’t miss out - subscribe today.
Worcester Business Journal presents a special commemorative edition celebrating the 300th anniversary of the city of Worcester. This landmark publication covers the city and region’s rich history of growth and innovation.
In order to use this feature, we need some information from you. You can also login or register for a free account.
By clicking submit you are agreeing to our cookie usage and Privacy Policy
Already have an account? Login
Already have an account? Login
Want to create an account? Register
In order to use this feature, we need some information from you. You can also login or register for a free account.
By clicking submit you are agreeing to our cookie usage and Privacy Policy
Already have an account? Login
Already have an account? Login
Want to create an account? Register
This website uses cookies to ensure you get the best experience on our website. Our privacy policy
To ensure the best experience on our website, articles cannot be read without allowing cookies. Please allow cookies to continue reading. Our privacy policy
0 Comments